C.H. Robinson Worldwide presents a striking contradiction this week: the stock has collapsed 23% over the past month to $143.66, yet short sellers are rushing for the exit, not the entrance.
Short interest has fallen sharply from a peak of more than 7.5 million shares in mid-July to roughly 4.8 million now — down nearly 30% over the past month. That drop brings SI to 4.1% of the free float, a meaningful but not extreme level. The week-on-week tick of 9% higher is worth noting, but it follows a steep multi-week unwind rather than a fresh build. The broader picture is one of shorts who piled in ahead of the July 29 earnings print — when the stock dropped 13% in a single session — and have been covering ever since. Borrow conditions confirm there is nothing pressured about the short book right now. Cost to borrow has eased 24% on the week to just 0.33%, a multi-month low. Availability is extraordinarily loose at 3,706% — more than 81 million shares sit available in the lending pool against roughly 4.8 million shorted, leaving shorts with no squeeze exposure whatsoever.
Options tell a bullish story. The put/call ratio has dropped to 0.31, more than two standard deviations below its 20-day average of 0.37. That is near the most call-heavy reading of the past year, suggesting options traders are positioning for recovery rather than bracing for further downside. The setup is unusual: a stock that has just been punished is being embraced in the options market, while short sellers are standing down.
The Street is divided on whether the earnings shock was a cyclical stumble or something more structural. Most analysts trimmed targets after the July 29 miss — TD Cowen came down to $152 and Baird cut to $200 — but the direction of travel was mixed rather than uniform. Stifel raised its target to $225 and maintained Buy, while Evercore ISI lifted to $237 on Outperform. Bernstein, the most recent action (August 11), nudged its target marginally lower to $151 while staying at Market Perform. The consensus mean target of $200 sits well above the current price, implying roughly 39% upside — though that gap reflects how far the stock has fallen rather than fresh conviction. The analyst recommendation divergence factor score ranks in the 98th percentile, which captures exactly this tension: a wide spread of views on a name where the story is genuinely uncertain. The bull case rests on secular outsourcing demand and technology investment paying off; the bear case centres on weak freight volumes, rising spot rates, and intensifying competition.
The most eye-catching institutional move is BlackRock adding 1.38 million shares in July to reach a 9.7% stake — the largest build among the top holders by a wide margin. First Trust added over 1 million shares in the same period. Against that backdrop, insiders have been net sellers: the CEO sold $2.1 million worth at $180 in late June, and the CFO sold $897,000 worth at $191 in early July, both well above the current price. The net insider flow over 90 days is modestly positive in share terms only because of small open-market purchases in February — the recent pattern at the executive level is clearly one of distribution into strength.
The next earnings date is October 28. The last print produced a 13% single-day drop and a further 9% loss over the following week. With the stock now trading at roughly $144, well below where even the most cautious analysts have set their targets, and with logistics peers EXPD and UPS both positive on the week while CHRW slipped 0.7%, the key question heading into Q3 is whether freight volumes have stabilised enough to prevent a repeat of July's downside surprise.
See the live data behind this article on ORTEX.
Open CHRW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
